Sec Form 13G Filing - Qiming U.S. Healthcare GP II LLC filing for ELEVATION ONCOLOGY INC (ELEV) - 2022-02-08

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

 

 

     
  UNITED STATES  
  SECURITIES AND EXCHANGE COMMISSION  
  Washington, D.C. 20549  
     

SCHEDULE 13G

 

Under the Securities Exchange Act of 1934
(Amendment No. )*

 

Elevation Oncology, Inc.

(Name of Issuer)

 

Common stock, $0.0001 par value per share

(Title of Class of Securities)

 

28623U101

(CUSIP Number)

 

June 29, 2021

(Date of Event Which Requires Filing of this Statement)

 

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

¨ Rule 13d-1(b)
x Rule 13d-1(c)
¨ Rule 13d-1(d)

 

*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

 

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 

 

 

 

 

 

CUSIP No. 28623U101
   
  1.

Names of Reporting Persons

Qiming U.S. Healthcare Fund II, L.P.

 
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) ¨
    (b) x (1)
 
  3. SEC Use Only
 
  4.

Citizenship or Place of Organization

Delaware

     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
5.

Sole Voting Power

0

 
6.

Shared Voting Power

2,370,142 shares (2)

 
7.

Sole Dispositive Power

0

 
8.

Shared Dispositive Power

2,370,142 shares (2)

 
  9. Aggregate Amount Beneficially Owned by Each Reporting Person
2,370,142 shares (2)
 
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
 
  11.

Percent of Class Represented by Amount in Row (9)

10.2% (3)

 
  12.

Type of Reporting Person (See Instructions)

PN

             

(1)This Schedule 13G is filed by Qiming U.S. Healthcare Fund II, L.P. (“Qiming”), Qiming U.S. Healthcare GP II, LLC (“Qiming GP”), Mark McDade (“McDade”) and Gary Rieschel (“Rieschel” and together with Qiming, Qiming GP and McDade, collectively, the “Reporting Persons”). The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.
(2)Shares are held by Qiming. Qiming GP is the sole general partner of Qiming. McDade and Rieschel are the managing partners of Qiming GP. Qiming GP, Rieschel and McDade share voting and investment authority over the shares held by Qiming.
(3)This calculation is based on 23,225,637 shares of Common Stock outstanding as of November 9, 2021, as reported in the Issuer’s Form 10-Q for the quarterly period ended September 30, 2021 filed on November 12, 2021 with the Securities and Exchange Commission (the “SEC”).

 

2

 

 

CUSIP No. 28623U101
 
  1.

Names of Reporting Persons

Qiming U.S. Healthcare GP II, LLC

 
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) ¨
    (b) x (1)
 
  3. SEC Use Only
 
  4.

Citizenship or Place of Organization

Delaware

     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
5.

Sole Voting Power

0

 
6.

Shared Voting Power

2,370,142 shares (2)

 
7.

Sole Dispositive Power

0

 
8.

Shared Dispositive Power

2,370,142 shares (2)

 
  9.

Aggregate Amount Beneficially Owned by Each Reporting Person

2,370,142 shares (2)

 
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  o
 
  11.

Percent of Class Represented by Amount in Row (9)

10.2% (3)

 
  12.

Type of Reporting Person (See Instructions)

OO

           

(1)This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.
(2)Shares are held by Qiming. Qiming GP is the sole general partner of Qiming. McDade and Rieschel are the managing partners of Qiming GP. Qiming GP, Rieschel and McDade share voting and investment authority over the shares held by Qiming.
(3)This calculation is based on 23,225,637 shares of Common Stock outstanding as of November 9, 2021, as reported in the Issuer’s Form 10-Q for the quarterly period ended September 30, 2021 filed on November 12, 2021 with the SEC.

 

3

 

 

CUSIP No. 28623U101
 
  1.

Names of Reporting Persons

Mark McDade

 
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) ¨
    (b) x (1)
 
  3. SEC Use Only
 
  4.

Citizenship or Place of Organization

United States of America

     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
5.

Sole Voting Power

0

 
6.

Shared Voting Power

2,370,142 shares (2)

 
7.

Sole Dispositive Power

0

 
8.

Shared Dispositive Power

2,370,142 shares (2)

 
  9.

Aggregate Amount Beneficially Owned by Each Reporting Person

2,370,142 shares (2)

 
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ¨
 
  11.

Percent of Class Represented by Amount in Row (9)

10.2% (3)

 
  12.

Type of Reporting Person (See Instructions)

IN

           

(1)This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.
(2)Shares are held by Qiming. Qiming GP is the sole general partner of Qiming. McDade and Rieschel are the managing partners of Qiming GP. Qiming GP, Rieschel and McDade share voting and investment authority over the shares held by Qiming.
(3)This calculation is based on 23,225,637 shares of Common Stock outstanding as of November 9, 2021, as reported in the Issuer’s Form 10-Q for the quarterly period ended September 30, 2021 filed on November 12, 2021 with the SEC.

 

4

 

 

CUSIP No. 28623U101
 
  1.

Names of Reporting Persons

Gary Rieschel

 
  2. Check the Appropriate Box if a Member of a Group (See Instructions)
    (a) ¨
    (b) x (1)
 
  3. SEC Use Only
 
  4.

Citizenship or Place of Organization

United States of America

     
Number of
Shares
Beneficially
Owned by
Each
Reporting
Person With
5.

Sole Voting Power

0

 
6.

Shared Voting Power

2,370,142 shares (2)

 
7.

Sole Dispositive Power

0

 
8.

Shared Dispositive Power

2,370,142 shares (2)

 
  9.

Aggregate Amount Beneficially Owned by Each Reporting Person

2,370,142 shares (2)

 
  10. Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)  ¨
 
  11.

Percent of Class Represented by Amount in Row (9)

10.2% (3)

 
  12.

Type of Reporting Person (See Instructions)

IN

           

(1)This Schedule 13G is filed by the Reporting Persons. The Reporting Persons expressly discla im status as a “group” for purposes of this Schedule 13G.
(2)Shares are held by Qiming. Qiming GP is the sole general partner of Qiming. McDade and Rieschel are the managing partners of Qiming GP. Qiming GP, Rieschel and McDade share voting and investment authority over the shares held by Qiming.
(3)This calculation is based on 23,225,637 shares of Common Stock outstanding as of November 9, 2021, as reported in the Issuer’s Form 10-Q for the quarterly period ended September 30, 2021 filed on November 12, 2021 with the SEC.

 

5

 

 

Item 1.
  (a)

Name of Issuer

Elevation Oncology, Inc.

  (b)

Address of Issuer’s Principal Executive Offices

888 Seventh Ave, 12th Floor

New York, NY 10106

 
Item 2.
  (a)

Name of Person Filing

Qiming U.S. Healthcare Fund II, L.P. (“Qiming”)

Qiming U.S. Healthcare GP II, LLC (“Qiming GP”)

Mark McDade (“McDade”)

Gary Rieschel (“Rieschel”)

  (b)

Address of Principal Business Office or, if none, Residence

11100 NE 8th Street, Suite 200

Bellevue, WA 98004

 

  (c) Citizenship
    Entities: Qiming - Delaware
      Qiming GP - Delaware
           
    Individuals: McDade - United States of America
      Rieschel - United States of America

 

  (d)

Title of Class of Securities

Common Stock, $0.0001 par value (“Common Stock”)

  (e)

CUSIP Number

28623U101

 
Item 3. If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
  Not applicable
 
Item 4. Ownership
     

Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1.

 

Reporting Persons  Shares Held
Directly
   Sole
Voting
Power
   Shared
Voting
Power
   Sole
Dispositive
Power
   Shared
Dispositive
Power
   Beneficial
Ownership
   Percentage
of Class (2)
 
Qiming (1)   2,370,142    0    2,370,142    0    2,370,142    2,370,142    10.2%
Qiming GP (1)   0    0    2,370,142    0    2,370,142    2,370,142    10.2%
McDade (1)   0    0    2,370,142    0    2,370,142    2,370,142    10.2%
Rieschel (1)   0    0    2,370,142    0    2,370,142    2,370,142    10.2%

 

(1)Shares are held by Qiming. Qiming GP is the sole general partner of Qiming. McDade and Rieschel are the managing partners of Qiming GP. Qiming GP, Rieschel and McDade share voting and investment authority over the shares held by Qiming.

(2)This calculation is based on 23,225,637 shares of Common Stock outstanding as of November 9, 2021, as reported in the Issuer’s Form 10-Q for the quarterly period ended September 30, 2021 filed on November 12, 2021 with the SEC.

 

6

 

 

Item 5. Ownership of Five Percent or Less of a Class
  If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following   ¨.
 
Item 6. Ownership of More than Five Percent on Behalf of Another Person
  Not applicable
 
Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company or Control Person
  Not applicable
 
Item 8. Identification and Classification of Members of the Group
  Not applicable
 
Item 9. Notice of Dissolution of Group
  Not applicable
 
Item 10. Certification
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having such purpose or effect.

 

7

 

 

Signature

 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

 

Dated: February 8, 2022

 

Qiming U.S. Healthcare Fund II, L.P.  
     
By: Qiming U.S. Healthcare GP II, LLC  
its General Partner  
     
By:  /s/ Mark McDade  
Name: Mark McDade   
  Title: Managing Member   
   
Qiming U.S. Healthcare GP II, LLC  
     
By:  /s/ Mark McDade  
  Name: Mark McDade   
Title: Managing Member   
     
     
/s/ Mark McDade  
Mark McDade  
     
     
/s/ Gary Rieschel  
Gary Rieschel  

 

  ATTENTION  
     
Intentional misstatements or omissions of fact constitute Federal Criminal Violations (See 18 U.S.C. 1001).

 

8

 

 

Exhibit(s):

 

A - Joint Filing Statement

 

9

 

 

EXHIBIT A

 

JOINT FILING STATEMENT

 

We, the undersigned, hereby express our agreement that the attached Schedule 13G (or any amendments thereto) relating to the Common Stock of Elevation Oncology, Inc. is filed on behalf of each of us.

 

Dated: February 8, 2022

 

Qiming U.S. Healthcare Fund II, L.P.  
     
By: Qiming U.S. Healthcare GP II, LLC  
its General Partner  
     
By:  /s/ Mark McDade  
Name: Mark McDade   
  Title: Managing Member   
   
Qiming U.S. Healthcare GP II, LLC  
     
By:  /s/ Mark McDade  
  Name: Mark McDade   
Title: Managing Member   
     
     
/s/ Mark McDade  
Mark McDade  
     
     
/s/ Gary Rieschel  
Gary Rieschel